| Product Code: ETC7309076 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Germany Lumasiran Market Overview |
3.1 Germany Country Macro Economic Indicators |
3.2 Germany Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Germany Lumasiran Market - Industry Life Cycle |
3.4 Germany Lumasiran Market - Porter's Five Forces |
3.5 Germany Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Germany Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Germany Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Germany Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Germany Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Germany Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Germany Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare genetic diseases in Germany |
4.2.2 Growing awareness and acceptance of RNA interference (RNAi) therapies |
4.2.3 Favorable regulatory environment supporting the development and commercialization of innovative treatments |
4.3 Market Restraints |
4.3.1 High cost associated with lumasiran treatment may limit adoption |
4.3.2 Limited reimbursement coverage for lumasiran therapy in Germany |
4.3.3 Competition from alternative treatments for rare genetic diseases |
5 Germany Lumasiran Market Trends |
6 Germany Lumasiran Market, By Types |
6.1 Germany Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Germany Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Germany Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Germany Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Germany Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Germany Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Germany Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Germany Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Germany Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Germany Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Germany Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Germany Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Germany Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Germany Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Germany Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Germany Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Germany Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Germany Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Germany Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Germany Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Germany Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Germany Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Germany Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Germany Lumasiran Market Import-Export Trade Statistics |
7.1 Germany Lumasiran Market Export to Major Countries |
7.2 Germany Lumasiran Market Imports from Major Countries |
8 Germany Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for lumasiran |
8.2 Adoption rate of lumasiran therapy among eligible patients |
8.3 Number of healthcare providers trained on prescribing and administering lumasiran |
9 Germany Lumasiran Market - Opportunity Assessment |
9.1 Germany Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Germany Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Germany Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Germany Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Germany Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Germany Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Germany Lumasiran Market - Competitive Landscape |
10.1 Germany Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Germany Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here